EBS - Emergent BioSolutions Inc. (EBS) CEO Dan Abdun-Nabi on Acquisition of Adapt Pharma and its Flagship Product NARCAN Nasal Spray Conference Call (Transcript)
Emergent BioSolutions Inc. (EBS)
Acquisition of Adapt Pharma and its Flagship Product NARCAN Nasal Spray Conference Call
August 28, 2018 05:00 PM ET
Executives
Bob Burrows - Vice President, Investor Relations
Dan Abdun-Nabi - Chief Executive Officer
Bob Kramer - President, Chief Operating Officer
Rich Lindahl - Executive Vice President, Chief Financial Officer
Adam Havey - Executive Vice President, Business Operations
Doug White - Senior Vice President and Devices Business Unit Head
Chris Frech - Senior Vice President, Global Government Affairs
Analysts
Brandon Folkes - Cantor Fitzgerald
David Maris - Wells Fargo
Chris Staral -